Enterprise Value

499.7M

Cash

129.2M

Avg Qtr Burn

-19.48M

Short % of Float

4.29%

Insider Ownership

22.29%

Institutional Own.

44.30%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Phase 2b

Data readout

Phase 2a

Data readout

Phase 2a

Data readout

Phase 2a

Data readout

AB-101 Details
Hepatitis B

Phase 1

Data readout

Phase 1a

Update

Failed

Discontinued

Failed

Discontinued